CME Group Inc. (NASDAQ:CME) Shares Bought by Matrix Trust Co

Matrix Trust Co grew its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 5.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,729 shares of the financial services provider’s stock after acquiring an additional 375 shares during the period. Matrix Trust Co’s holdings in CME Group were worth $1,628,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in CME. AE Wealth Management LLC boosted its holdings in shares of CME Group by 25.5% in the 3rd quarter. AE Wealth Management LLC now owns 2,543 shares of the financial services provider’s stock valued at $509,000 after buying an additional 516 shares during the period. Koshinski Asset Management Inc. acquired a new position in shares of CME Group in the 3rd quarter valued at about $298,000. Oak Thistle LLC acquired a new position in shares of CME Group in the 3rd quarter valued at about $462,000. Asset Management One Co. Ltd. boosted its holdings in shares of CME Group by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 211,208 shares of the financial services provider’s stock valued at $42,288,000 after buying an additional 7,927 shares during the period. Finally, Ballentine Partners LLC boosted its holdings in shares of CME Group by 3.2% in the 3rd quarter. Ballentine Partners LLC now owns 5,073 shares of the financial services provider’s stock valued at $1,016,000 after buying an additional 159 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on CME. Bank of America lifted their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday. The Goldman Sachs Group downgraded shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a research report on Wednesday, January 3rd. Barclays lifted their price objective on shares of CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $210.00 price objective (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Rosenblatt Securities reiterated a “sell” rating and issued a $187.00 price objective (up from $185.00) on shares of CME Group in a research report on Thursday. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $217.80.

Read Our Latest Research Report on CME

CME Group Price Performance

Shares of CME stock traded down $1.60 during midday trading on Friday, reaching $210.94. 1,353,130 shares of the company were exchanged, compared to its average volume of 1,722,282. CME Group Inc. has a 12 month low of $175.73 and a 12 month high of $223.80. The company has a market cap of $75.94 billion, a P/E ratio of 24.00, a PEG ratio of 5.92 and a beta of 0.49. The company’s 50 day moving average price is $214.73 and its two-hundred day moving average price is $211.90. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.42 EPS. On average, sell-side analysts expect that CME Group Inc. will post 9.67 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.18%. This is a boost from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is currently 52.33%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.